What are the new French recommendations for the treatment of postmenopausal osteoporosis?

被引：0
作者：
Blain, H. [1 ]
机构：
[1] Univ Montpellier, Pole Gerontol, CHU Montpellier, Serv Med Interne Geriatrie,Ctr Antonin Balmes, 39 Ave Charles Flahaut, F-34295 Montpellier 5, France
来源：
REVUE DE MEDECINE INTERNE | 2019年 / 40卷 / 05期
关键词：
Osteoporosis; Fracture; Guidelines; FRACTURES; WOMEN;
D O I：
10.1016/j.revmed.2018.05.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：275 / 277
页数：3
相关论文
共 50 条
  • [21] Sclerostin inhibition: A novel target for the treatment of postmenopausal osteoporosis
    Aditya, Suruchi
    Rattan, Aditya
    JOURNAL OF MID-LIFE HEALTH, 2021, 12 (04) : 267 - 275
  • [22] Three years of treatment with minodronate in patients with postmenopausal osteoporosis
    Hagino, Hiroshi
    Shiraki, Masataka
    Fukunaga, Masao
    Nakano, Tetsuo
    Takaoka, Kunio
    Ohashi, Yasuo
    Nakamura, Toshitaka
    Matsumoto, Toshio
    JOURNAL OF BONE AND MINERAL METABOLISM, 2012, 30 (04) : 439 - 446
  • [23] Is there a place for menopausal hormonal therapy in the treatment of postmenopausal osteoporosis?
    Slopien, R.
    Khadka, S.
    Englert-Golon, M.
    Pisarska-Krawczyk, M.
    Sajdak, S.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2018, 45 (03) : 325 - 327
  • [24] Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis
    Ma Chao
    Qin Hua
    Zhou Yingfeng
    Wan Guang
    Shi Shufeng
    Dong Yuzhen
    Wang Wei
    Tan Haifeng
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 (06) : 1381 - 1384
  • [25] Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis
    Kung, Annie W. C.
    Chu, Eva Y. W.
    Xu, Ling
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (08) : 1377 - 1385
  • [26] Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
    Moro-Alvarez, Maria J.
    Diaz-Curiel, Manuel
    CLINICAL INTERVENTIONS IN AGING, 2008, 3 (02) : 227 - 232
  • [27] TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH TRANSDERMAL ESTROGEN
    LUFKIN, EG
    WAHNER, HW
    OFALLON, WM
    HODGSON, SF
    KOTOWICZ, MA
    LANE, AW
    JUDD, HL
    CAPLAN, RH
    RIGGS, BL
    ANNALS OF INTERNAL MEDICINE, 1992, 117 (01) : 1 - 9
  • [28] Denosumab - an emerging treatment for postmenopausal osteoporosis
    Lewiecki, E. Michael
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 467 - 476
  • [29] Treatment options for postmenopausal osteoporosis in Asia
    Chu, Eva Yuet-wah
    Tsang, Shirley Wan-yin
    Kung, Annie Wai-chee
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2008, 11 (04) : 386 - 392
  • [30] The Effectiveness of Denosumab in the Treatment of Postmenopausal Osteoporosis
    Aras, Berke
    Kuzu, Omer
    ERCIYES MEDICAL JOURNAL, 2022, 44 (03) : 312 - 317
12345